David Duane House - 05 Feb 2025 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARMP	Stock Options (Right to Buy)	Award	$0	+25,000		$0.000000	25,000	05 Feb 2025	Common Stock	25,000	$2.04	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Twenty-five percent (25%) of the Stock Options shall vest on February 5th of each of 2026, 2027, 2028 and 2029, in each case subject to continuous service through the applicable vesting date.